OLMA: Olema Pharmaceuticals, Inc. Stock

by  •  • Comments Off on OLMA: Olema Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 549.64
Enterprise Value ($M) 481.10
Book Value ($M) 253.90
Book Value / Share 4.54
Price / Book 2.16
NCAV ($M) 243.46
NCAV / Share 4.35
Price / NCAV 2.26

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.49
Return on Equity (ROE) -0.55

Liquidity (mrq)
Quick Ratio 12.33
Current Ratio 12.33

Balance Sheet (mrq) ($M)
Current Assets 266.51
Assets 276.94
Liabilities 23.05
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -104.96
Net Income -96.66

Cash Flow Statement (mra) ($M)
Cash From Operations -83.73
Cash from Investing -4.85
Cash from Financing 133.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-22 13G Deep Track Capital, LP 5.44
02-14 13G/A Cormorant Asset Management, LP 4.49 18.00
02-14 13G/A Kynam Capital Management, LP 0.00 -100.00
02-14 13G/A Paradigm Biocapital Advisors LP 14.30 1.28
02-12 13G/A Janus Henderson Group Plc 1.30 -77.10
01-29 13G BlackRock Inc. 6.00 150.01
11-28 13D/A Logos Global Management LP 7.80 13.52
09-14 13D/A Biotechnology Value Fund L P 16.70 23.27

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 94,861 338,886 27.99
2024-04-25 174,155 1,136,216 15.33
2024-04-24 51,086 227,662 22.44
2024-04-23 37,844 243,986 15.51
2024-04-22 57,504 444,951 12.92

(click for more detail)

Similar Companies
NVAX – Novavax, Inc. NXTC – NextCure, Inc.
OGI – Organigram Holdings Inc. OMGA – Omega Therapeutics, Inc.
OPK – OPKO Health, Inc.


Financial data and stock pages provided by
Fintel.io